AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29290563 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator-piloted pulmonary recruitment maneuver (PRM)
Number of subjects: 150
Study 29290563 — intervention group
Group type: COMPARATOR
Intervention: Routine exsufflation (control group)
Number of subjects: 150
Study 26804640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 25 mg of cinacalcet
Number of subjects: 42
Study 26804640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 50 mg of cinacalcet
Number of subjects: 42
Study 26804640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 100 mg of cinacalcet
Number of subjects: 42
Study 26804640 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of 50 mg of cinacalcet once daily for 7 days
Number of subjects: 42
Study 26804640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet administration (single and multiple doses)
Number of subjects: 42
Study 24629181 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocker-sole footwear (MBT® Matwa, Masai Barefoot Technology, Switzerland)
Number of subjects: 80
Study 24629181 — intervention group
Group type: COMPARATOR
Intervention: Individualised prefabricated foot orthoses (Vasyli Customs, Vasyli Medical™, Queensland, Australia)
Number of subjects: 80
Study 22353201 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 at 25 mg twice daily for 5 days (level 1)
Number of subjects: 12
Study 22353201 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 at 40 mg twice daily for 5 days (level 2)
Number of subjects: 12
Study 22353201 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 12
Study 20584700 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of the alcohol-based hand-rub dispenser in clear view of physicians
Number of subjects: 52
Study 20584700 — intervention group
Group type: COMPARATOR
Intervention: Placement of the alcohol-based hand-rub dispenser not in the field of view
Number of subjects: 52
Study 17393237 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide and formoterol
Number of subjects: 36
Study 15538607 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 190
Study 15538607 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 190
Study 11350520 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B 3D Plaque Remover (3D)
Number of subjects: 40
Study 11350520 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B D9
Number of subjects: 40
Study 11350520 — intervention group
Group type: COMPARATOR
Intervention: Philips/Jordan HP 735
Number of subjects: 40
Study 10346658 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive nutrition intervention for 3 months
Number of subjects: 18
Study 10346658 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 8036887 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 IU/r‐IL‐2/day
Number of subjects: 22
Study 8036887 — intervention group
Group type: COMPARATOR
Intervention: 500,000 IU/r‐IL‐2/day
Number of subjects: 22
Study 3289861 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical hyperbaric oxygen (THO) treatment for 2 weeks
Number of subjects: 28
Study 3289861 — intervention group
Group type: COMPARATOR
Intervention: Control group (no THO treatment)
Number of subjects: 28
Study 31181564 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 46
Study 31181564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 28645969 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational training (experimental arm)
Number of subjects: 14
Study 28645969 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no motivational training)
Number of subjects: 14
Study 26244877 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus docetaxel (75 mg/m² every 3 weeks for six cycles)
Number of subjects: 790
Study 26244877 — intervention group
Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 790
Study 26244877 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus docetaxel
Number of subjects: 790
Study 24195207 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + medication (SSRIs)
Number of subjects: 90
Study 24195207 — intervention group
Group type: COMPARATOR
Intervention: Medication (SSRIs)
Number of subjects: 90
Study 21383112 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational individual program
Number of subjects: 111
Study 21383112 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 111
Study 19321522 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced use group (wore a restraining sling on the non-paretic arm for up to 6 hours per weekday for two weeks)
Number of subjects: 30
Study 19321522 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (participated in two weeks of daily training on weekdays)
Number of subjects: 30
Study 15889626 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral parenting skills training, social skills training, and supplemental reading instruction
Number of subjects: 0
Study 15889626 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 10516943 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate 400 mg orally every 6 hours with placebo
Number of subjects: 12
Study 10516943 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP 160 mg/SMZ 800 mg orally every 12 hours with placebo
Number of subjects: 12
Study 10516943 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate with TMP/SMZ
Number of subjects: 12
Study 7586112 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine 1 mg.kg‐1 (SxCh)
Number of subjects: 60
Study 7586112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.3 mg.kg‐1 (Vec 0.3)
Number of subjects: 60
Study 7586112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg.kg‐1 (Vec 0.5)
Number of subjects: 60
Study 7586112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg.kg‐1 (Vec 0.5) in beta blocker group
Number of subjects: 60
Study 2149512 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5-10 mg bid)
Number of subjects: 83
Study 2149512 — intervention group
Group type: COMPARATOR
Intervention: Prazosin (2-8 mg bid)
Number of subjects: 83
Study 6118248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (acid-inhibitory and non-acid-inhibitory dosages)
Number of subjects: 18
Study 6118248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (various doses)
Number of subjects: 18
Study 31822689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958' at 150 kg N ha‐1
Number of subjects: 4
Study 31822689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958' at 0 kg N ha‐1
Number of subjects: 4
Study 31822689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958'
Number of subjects: 4
Study 30280946 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 1596
Study 30280946 — intervention group
Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 1596
Study 30280946 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 1596
Study 30280946 — intervention group
Group type: COMPARATOR
Intervention: CE 0.45 mg/MPA 1.5 mg
Number of subjects: 1596
Study 30280946 — intervention group
Group type: EXPERIMENTAL
Intervention: CE/BZA doses and Placebo
Number of subjects: 1596
Study 27267151 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM) intervention combined with usual care
Number of subjects: 35
Study 27267151 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 35
Study 25138548 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution computed tomography (HRCT)
Number of subjects: 34
Study 25138548 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhaled nitric oxide (FENO)
Number of subjects: 34
Study 25138548 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological markers in induced sputum (MMP-9 and TIMP-1)
Number of subjects: 34
Study 25138548 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophilia in sputum
Number of subjects: 34
Study 22743565 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin analog treatment
Number of subjects: 0
Study 22743565 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 19148406 — intervention group
Group type: EXPERIMENTAL
Intervention: InCeram Zirconia crowns
Number of subjects: 20
Study 19148406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cercon Zirconia crowns
Number of subjects: 20
Study 19148406 — intervention group
Group type: COMPARATOR
Intervention: Both InCeram and Cercon Zirconia crowns
Number of subjects: 20
Study 17444313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intersurgical Scented mask
Number of subjects: 30
Study 17444313 — intervention group
Group type: COMPARATOR
Intervention: Black rubber mask
Number of subjects: 30
Study 16323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program (n = 15)
Number of subjects: 30
Study 16323386 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study 12110964 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiment 1 - varying initial position of the limb
Number of subjects: 0
Study 12110964 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiment 2 - matched change in position of the limb and monitor display
Number of subjects: 0
Study 12110964 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiment 3 - fixed initial position of the limb, varying monitor display location
Number of subjects: 0
Study 9558685 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular rate stabilization (VRS) pacing
Number of subjects: 16
Study 9558685 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 16
Study 8596815 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSol PDS 22‐4 (irrigating solution)
Number of subjects: 30
Study 8596815 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 30
Study 2755712 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis treatment
Number of subjects: 66
Study 2755712 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 66
Study 31484523 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO‐based remote follow‐up
Number of subjects: 0
Study 31484523 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO‐based telephone consultation
Number of subjects: 0
Study 31484523 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient follow‐up (control group)
Number of subjects: 0
Study 28028619 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed beef protein
Number of subjects: 27
Study 28028619 — intervention group
Group type: COMPARATOR
Intervention: Whey protein
Number of subjects: 27
Study 28028619 — intervention group
Group type: COMPARATOR
Intervention: Non-protein isoenergetic carbohydrate
Number of subjects: 27
Study 26499250 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS‐working memory (DCS‐WM)
Number of subjects: 100
Study 26499250 — intervention group
Group type: COMPARATOR
Intervention: tDCS‐control cognitive training (DCS‐CC)
Number of subjects: 100
Study 26499250 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS‐working memory (WM‐CD)
Number of subjects: 100
Study 23255145 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical perfluorodecalin (PFD) with R0 method (3 passes)
Number of subjects: 29
Study 23255145 — intervention group
Group type: EXPERIMENTAL
Intervention: R0 method (3 passes with PFD)
Number of subjects: 29
Study 23255145 — intervention group
Group type: COMPARATOR
Intervention: Single pass method
Number of subjects: 29
Study 23255145 — intervention group
Group type: COMPARATOR
Intervention: R20 method
Number of subjects: 29
Study 23255145 — intervention group
Group type: EXPERIMENTAL
Intervention: PFD application
Number of subjects: 29
Study 21254315 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (45 min)
Number of subjects: 33
Study 21254315 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (45 min/day for 4 weeks)
Number of subjects: 33
Study 21254315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 21254315 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (4 weeks)
Number of subjects: 33
Study 19497597 — intervention group
Group type: EXPERIMENTAL
Intervention: ExCHO - 80-minute resistance exercise bout while consuming CHO (approximately 77 g CHO, 306 kcal)
Number of subjects: 21
Study 19497597 — intervention group
Group type: EXPERIMENTAL
Intervention: ExPLA - identical exercise with a non-caloric placebo
Number of subjects: 21
Study 19497597 — intervention group
Group type: COMPARATOR
Intervention: NoExCHO - no-exercise trial of quiet sitting and CHO consumption
Number of subjects: 21
Study 19497597 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 21
Study 19497597 — intervention group
Group type: EXPERIMENTAL
Intervention: ExCHO and ExPLA
Number of subjects: 21
Study 17457160 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (blood volume equal to approximately 0.7% of the patient's body weight collected before liver transection)
Number of subjects: 79
Study 17457160 — intervention group
Group type: COMPARATOR
Intervention: Control group (no blood salvage)
Number of subjects: 79
Study 17457160 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage
Number of subjects: 79
Study 17457160 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study 15865035 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse coloplasty pouch (TCP)
Number of subjects: 106
Study 15865035 — intervention group
Group type: COMPARATOR
Intervention: Colon J-pouch (CJP)
Number of subjects: 106
Study 11695214 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Plus Whitening Toothpaste
Number of subjects: 123
Study 11695214 — intervention group
Group type: COMPARATOR
Intervention: Crest Multi‐Care Advanced Cleaning Toothpaste
Number of subjects: 123
Study 11695214 — intervention group
Group type: COMPARATOR
Intervention: Colgate Winterfresh Gel Fluoride Toothpaste
Number of subjects: 123
Study 9585725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomoxetine (76 mg/day)
Number of subjects: 22
Study 9585725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9585725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomoxetine
Number of subjects: 22
Study 7814794 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 18
Study 7814794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2672610 — intervention group
Group type: EXPERIMENTAL
Intervention: Migen (M)
Number of subjects: 60
Study 2672610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmalgen (P)
Number of subjects: 60
Study 2672610 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study 791107 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (2 mg/kg at the beginning, at 12 h, and once daily)
Number of subjects: 51
Study 791107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 791107 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride (administered at 6-h intervals)
Number of subjects: 51
Study 30173574 — intervention group
Group type: EXPERIMENTAL
Intervention: Early driving (2-3 weeks post birth)
Number of subjects: 66
Study 30173574 — intervention group
Group type: COMPARATOR
Intervention: Late driving (5-6 weeks post birth)
Number of subjects: 66
Study 31577396 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate therapeutic hypothermia (33°C during the first 24 hours)
Number of subjects: 581
Study 31577396 — intervention group
Group type: COMPARATOR
Intervention: Targeted normothermia (37°C)
Number of subjects: 581
Study 31577396 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate therapeutic hypothermia (33°C)
Number of subjects: 581
Study 28349044 — intervention group
Group type: EXPERIMENTAL
Intervention: VPZ-based treatment (VPZ 20 mg, amoxicillin 750 mg, and clarithromycin 200 or 400 mg twice daily for 7 days)
Number of subjects: 141
Study 28349044 — intervention group
Group type: COMPARATOR
Intervention: PPI-based treatment (rabeprazole 20 mg or lansoprazole 30 mg, amoxicillin 750 mg, and clarithromycin 200 or 400 mg twice daily for 7 days)
Number of subjects: 141
Study 28349044 — intervention group
Group type: EXPERIMENTAL
Intervention: VPZ-based treatment
Number of subjects: 141
Study 28349044 — intervention group
Group type: COMPARATOR
Intervention: PPI-based treatment
Number of subjects: 141
Study 25253443 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard information plus 'The Gist' leaflet (Gist + Facts, n = 2,236)
Number of subjects: 4452
Study 25253443 — intervention group
Group type: COMPARATOR
Intervention: Standard information ('The Facts', n = 2,216)
Number of subjects: 4452
Study 25253443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Gist + Facts and Facts)
Number of subjects: 4452
Study 23725941 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity colonoscopy model (AccuTouch CS)
Number of subjects: 32
Study 23725941 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity colonoscopy model
Number of subjects: 32
Study 21536441 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral hip isokinetic exercises of the dominant leg for two weeks
Number of subjects: 32
Study 21536441 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 18053998 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic conjugated estrogens B (0.3 mg/d)
Number of subjects: 310
Study 18053998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 17212913 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment (medications, physical therapy, epidural steroid injections)
Number of subjects: 0
Study 17212913 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (laminectomy)
Number of subjects: 0
Study 14975774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue condition (glove puppets and post boxes)
Number of subjects: 96
Study 14975774 — intervention group
Group type: COMPARATOR
Intervention: No cue condition
Number of subjects: 96
Study 11349266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF), 1 g twice daily intravenously followed by 1.5 g twice daily orally
Number of subjects: 565
Study 11349266 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA), 1.0 to 2.0 mg/kg/d intravenously followed by oral administration
Number of subjects: 565
Study 11349266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 565
Study 11349266 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 565
Study 11349266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) and Azathioprine (AZA)
Number of subjects: 565
Study 8480551 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) with salbutamol (S)
Number of subjects: 36
Study 8480551 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DNCG) with salbutamol (S)
Number of subjects: 36
Study 8480551 — intervention group
Group type: COMPARATOR
Intervention: Placebo with salbutamol (S)
Number of subjects: 36
Study 3435159 — intervention group
Group type: EXPERIMENTAL
Intervention: Human normal immunoglobulin (50 mg/kg) administered weekly via intramuscular injection
Number of subjects: 120
Study 3435159 — intervention group
Group type: COMPARATOR
Intervention: Non-treated group (control)
Number of subjects: 120
Study 29564942 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous closure of patent foramen ovale (PFO)
Number of subjects: 0
Study 29564942 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 0
Study 27033672 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine plus intensity-modulated radiotherapy (gem-IMRT)
Number of subjects: 0
Study 27033672 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine plus stereotactic body radiotherapy (gem-SBRT)
Number of subjects: 0
Study 27033672 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine alone (gem-alone)
Number of subjects: 0
Study 25558162 — intervention group
Group type: EXPERIMENTAL
Intervention: Varunadi Ghritha, 5gms twice daily for one year
Number of subjects: 78
Study 25558162 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 78
Study 23548529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecallantide 30 mg subcutaneously
Number of subjects: 98
Study 20038852 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (100,000-200,000 IU)
Number of subjects: 79
Study 20038852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 20038852 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 79
Study 18538051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg kg(‐1) loading dose followed by 0.2 microg kg(‐1) h(‐1))
Number of subjects: 49
Study 18538051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 49
Study 18538051 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Fentanyl (0.05 mg kg(‐1) midazolam and 1 microg kg(‐1) fentanyl)
Number of subjects: 49
Study 18538051 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Fentanyl
Number of subjects: 49
Study 16905079 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% xenon and 1.5% sevoflurane (X50-S1.5)
Number of subjects: 32
Study 16905079 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% xenon and 1.5% sevoflurane (X70-S1.5)
Number of subjects: 32
Study 16905079 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% nitrous oxide and 1.5% sevoflurane (G70-S1.5)
Number of subjects: 32
Study 16905079 — intervention group
Group type: COMPARATOR
Intervention: 2.8% sevoflurane (S2.8)
Number of subjects: 32
Study 14603706 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0